Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 10/20 | 0.51 |
| ▸ | RAB9A | P51151 | 10/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.51 |
| ▸ | TP53 | P04637 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20865042 | 0.81 | SIGMAR1 (0.42) | KMT2AMEN1 | |
| SCHEMBL22303485 | 0.77 | NPC1 (0.40) | NPC1RAB9ASMN1; SMN2TP53KMT2A | |
| SCHEMBL683906 | 0.73 | ALOX5 (0.57) | RAB9ASMN1; SMN2GAALMNAMAPK1 | |
| SCHEMBL7690199 | 0.73 | GRIN1 (0.72) | NPC1RAB9ASMN1; SMN2TP53KMT2A | |
| SCHEMBL20865069 | 0.72 | MAPT (0.55) | NPC1RAB9ASMN1; SMN2TP53KMT2A | |
| SCHEMBL29783449 | 0.72 | MAPT (0.55) | NPC1RAB9ASMN1; SMN2TP53KMT2A | |
| SCHEMBL8640793 | 0.72 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2TP53KMT2A | |
| SCHEMBL20865040 | 0.72 | CYP4F2 (0.48) | LMNA | |
| SCHEMBL10745905 | 0.71 | AMY1A (0.53) | NPC1RAB9ASMN1; SMN2TP53KMT2A | |
| SCHEMBL31166963 | 0.71 | ALOX5 (0.50) | RAB9ASMN1; SMN2KMT2AGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200246240-A1 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | L'OREAL (FR) | 2020-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200246240-A1 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | KRT18, RARA, RBP4 | NPC1 1249/4885RAB9A 545/4885SMN1; SMN2 4685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.